Correlation Between Monster Beverage and Integrated Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monster Beverage and Integrated Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monster Beverage and Integrated Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monster Beverage Corp and Integrated Diagnostics Holdings, you can compare the effects of market volatilities on Monster Beverage and Integrated Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monster Beverage with a short position of Integrated Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monster Beverage and Integrated Diagnostics.

Diversification Opportunities for Monster Beverage and Integrated Diagnostics

-0.17
  Correlation Coefficient

Good diversification

The 3 months correlation between Monster and Integrated is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Monster Beverage Corp and Integrated Diagnostics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integrated Diagnostics and Monster Beverage is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monster Beverage Corp are associated (or correlated) with Integrated Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integrated Diagnostics has no effect on the direction of Monster Beverage i.e., Monster Beverage and Integrated Diagnostics go up and down completely randomly.

Pair Corralation between Monster Beverage and Integrated Diagnostics

Assuming the 90 days trading horizon Monster Beverage Corp is expected to under-perform the Integrated Diagnostics. But the stock apears to be less risky and, when comparing its historical volatility, Monster Beverage Corp is 2.96 times less risky than Integrated Diagnostics. The stock trades about -0.31 of its potential returns per unit of risk. The Integrated Diagnostics Holdings is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  44.00  in Integrated Diagnostics Holdings on October 15, 2024 and sell it today you would earn a total of  3.00  from holding Integrated Diagnostics Holdings or generate 6.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy94.74%
ValuesDaily Returns

Monster Beverage Corp  vs.  Integrated Diagnostics Holding

 Performance 
       Timeline  
Monster Beverage Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Monster Beverage Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Monster Beverage is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Integrated Diagnostics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Integrated Diagnostics Holdings are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Integrated Diagnostics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Monster Beverage and Integrated Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monster Beverage and Integrated Diagnostics

The main advantage of trading using opposite Monster Beverage and Integrated Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monster Beverage position performs unexpectedly, Integrated Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Diagnostics will offset losses from the drop in Integrated Diagnostics' long position.
The idea behind Monster Beverage Corp and Integrated Diagnostics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Fundamental Analysis
View fundamental data based on most recent published financial statements
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Valuation
Check real value of public entities based on technical and fundamental data